Open AccessJournal Article
Carbons Into Bytes: Patented Chemical Compound Protection in the Virtual World
Reads0
Chats0
TLDR
This Issue Brief argues that virtual compound claims are not abstract ideas and therefore, consistent with patent policy, qualify as patentable subject matter.Abstract:
“Virtual” molecular compounds, created in molecular modeling software, are increasingly useful in the process of rational drug design. When a physical compound is patented, however, virtual use of the compound allows researchers to circumvent the protection granted to the patentee. To acquire protection from unauthorized use of compounds in their virtual form, patentees must directly claim the virtual compound. But Supreme Court decisions such as Bilski v. Kappos and Mayo Collaborative Services v. Prometheus Laboratories, Inc. call into question whether virtual compound claims are patentable subject matter under § 101. Using the guidance offered by the Supreme Court and Federal Circuit, this Issue Brief argues that virtual compound claims are not abstract ideas and therefore, consistent with patent policy, qualify as patentable subject matter.read more
Citations
More filters
OtherDOI
3D Printing and Intellectual Property
TL;DR: In this paper, Lucas S. Osborn focuses on the novel issues raised for IP law by 3D printing for the major IP systems around the world and specifically addresses how patent and design law must wrestle with protecting digital versions of inventions and policing individualized manufacturing.
Journal ArticleDOI
Digital Patent Infringement in an Era of 3D Printing
TL;DR: In this article, the authors consider whether offers to sell and sell of CAD files alone constitute direct patent infringement and conclude that such commercial activity is an appropriation of the economic value of the patent invention.
Journal Article
A Case for Weakening Patent Rights
Book ChapterDOI
The Patent Eligibility of Synthetic Biology Inventions
TL;DR: In this article, the authors investigated the subject matter eligibility of synthetic biology inventions and assessed the US laws of nature doctrine in relation to the patent application of SynBio inventions in Europe.